PL2501375T3 - Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe - Google Patents

Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe

Info

Publication number
PL2501375T3
PL2501375T3 PL10779550T PL10779550T PL2501375T3 PL 2501375 T3 PL2501375 T3 PL 2501375T3 PL 10779550 T PL10779550 T PL 10779550T PL 10779550 T PL10779550 T PL 10779550T PL 2501375 T3 PL2501375 T3 PL 2501375T3
Authority
PL
Poland
Prior art keywords
fatty acids
compositions containing
free fatty
containing free
antimicrobial compositions
Prior art date
Application number
PL10779550T
Other languages
English (en)
Inventor
Michael Anthony Folan
Original Assignee
Folan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Folan filed Critical Folan
Publication of PL2501375T3 publication Critical patent/PL2501375T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10779550T 2009-11-17 2010-11-17 Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe PL2501375T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20090872 2009-11-17
PCT/EP2010/067710 WO2011061237A1 (en) 2009-11-17 2010-11-17 Antimicrobial compositions containing free fatty acids
EP10779550.2A EP2501375B1 (en) 2009-11-17 2010-11-17 Antimicrobial compositions containing free fatty acids

Publications (1)

Publication Number Publication Date
PL2501375T3 true PL2501375T3 (pl) 2017-12-29

Family

ID=43412541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10779550T PL2501375T3 (pl) 2009-11-17 2010-11-17 Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe

Country Status (7)

Country Link
US (4) US20120289591A1 (pl)
EP (1) EP2501375B1 (pl)
CN (2) CN102639129B (pl)
CA (1) CA2781550C (pl)
ES (1) ES2643862T3 (pl)
PL (1) PL2501375T3 (pl)
WO (1) WO2011061237A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
CN102639129B (zh) 2009-11-17 2016-08-24 迈克尔·A·福兰 含游离脂肪酸的抗微生物组合物
NL2009407C2 (en) * 2012-09-03 2014-03-04 Dutch Renewable Energy B V Antimicrobial composition.
WO2015077798A1 (en) * 2013-11-25 2015-05-28 Excelsior Medical Corporation Catheter lock solution formulations
WO2016051767A1 (en) * 2014-09-30 2016-04-07 The Kitasato Institute Narrow-spectrum antibacterial antibiotics targeting specific types of bacteria that synthesizes menaquinone through an alternative pathway via futalosine or 6-aminodeoxyfutalosine as an intermediate.
EP3220744A4 (en) 2014-11-19 2018-08-01 Kansas State University Research Foundation Chemical mitigants in animal feed and feed ingredients
JP6579529B2 (ja) * 2015-01-23 2019-09-25 バイオシディウム アイピー ホルコ カンパニー 抗菌組成物
EP3288534B1 (en) * 2015-04-28 2020-09-23 Symrise AG Compositions comprising valerian extracts
CN106551902B (zh) 2015-09-17 2020-07-03 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
US9826912B2 (en) 2015-11-11 2017-11-28 Livassured B.V. Photoplethysmographic device for measuring a heart rhythm
WO2017100580A1 (en) * 2015-12-10 2017-06-15 Aaron Seitz Sphingolipid coatings and process for manufacturing sphingolipid coatings effective for inhibiting biofilm formation
CN106913563A (zh) * 2016-01-04 2017-07-04 广东工业大学 多烯脂肪酸类化合物在制备抗耐药菌药物中的应用
JP6947756B2 (ja) 2016-02-22 2021-10-13 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System 抗菌組成物およびその使用
CN115990296A (zh) 2017-09-22 2023-04-21 贝克顿·迪金森公司 用作导管封管液的4%柠檬酸三钠溶液
WO2019108602A1 (en) * 2017-11-28 2019-06-06 University Of Florida Research Foundation Methods and compositions for retinal drug delivery
JP7077030B2 (ja) * 2018-01-29 2022-05-30 三菱鉛筆株式会社 筆記具用水性インク組成物
CN108605933B (zh) * 2018-04-20 2021-06-15 上海康归生物科技有限公司 一种脂肪酸复合物
KR102529645B1 (ko) * 2019-12-26 2023-05-08 고려대학교 산학협력단 리놀레산을 포함하는 생물막 형성 억제용 조성물 및 이를 이용한 생물막 형성 억제 방법
EP4093375A1 (en) 2020-01-21 2022-11-30 Boehringer Ingelheim Vetmedica GmbH Expanded foam for delivery of functional ingredients
US11298379B2 (en) * 2020-04-16 2022-04-12 James F. Kane Compositions comprising milk fat globules and methods of making same
US20220087257A1 (en) * 2020-09-23 2022-03-24 Sidharth Sareen Anti-Microbial Agent
KR102566917B1 (ko) * 2021-03-16 2023-08-14 영남대학교 산학협력단 쏘팔메토 오일 및 이의 불포화 지방산을 유효성분으로 함유하는 다중 병원성 미생물 바이오필름 형성 억제용 조성물
KR102659787B1 (ko) * 2022-01-11 2024-04-23 국민대학교산학협력단 베헨산을 포함하는 바이오필름 형성 억제용 조성물
CN115607677A (zh) * 2022-05-06 2023-01-17 太阳雨林(北京)生物医药有限公司 预防、阻止或治疗微生物感染的复合物及其制备和应用
KR20240061133A (ko) 2022-10-31 2024-05-08 전종열 화장품, 생활용품 및 손 세정제용 항균 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864707A (en) * 1956-01-16 1958-12-16 Union Carbide Corp Beverage concentrates and syrups
FR2324354A1 (fr) * 1974-07-25 1977-04-15 Equip Automobile Ste Fse Composition pour la mise en emulsion aqueuse biodegradable des hydrocarbures et graisses et son procede de preparation
US4164594A (en) * 1977-05-25 1979-08-14 Carnation Company Lecithin based wetting agent
DE69433759T2 (de) * 1993-07-30 2005-03-31 Aruba International Pty. Ltd., Rocklea Plasmadelipidationssystem
WO1997016517A1 (en) * 1995-10-30 1997-05-09 The Procter & Gamble Company Thickened, highly aqueous, cost effective liquid detergent compositions
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
US6281175B1 (en) * 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
GB0114014D0 (en) * 2001-06-08 2001-08-01 Novartis Nutrition Ag Compostion and use
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
DE60227389D1 (de) * 2001-08-23 2008-08-14 Westgate Biolog Ltd Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
WO2005117600A1 (en) * 2004-06-03 2005-12-15 Pacifica Resources Sdn.Bhd. A food surfactant
US7749529B2 (en) * 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
PL2051691T3 (pl) * 2006-10-13 2010-10-29 Evonik Degussa Gmbh Kompozycja do leczenia skóry
KR20100108526A (ko) * 2007-12-04 2010-10-07 웨스트게이트 바이올로지컬 리미티드 지방산 및 우유 단백질을 포함하는 항균성 조성물
CN102639129B (zh) 2009-11-17 2016-08-24 迈克尔·A·福兰 含游离脂肪酸的抗微生物组合物

Also Published As

Publication number Publication date
CN102639129B (zh) 2016-08-24
US9555116B2 (en) 2017-01-31
EP2501375A1 (en) 2012-09-26
CN106236708A (zh) 2016-12-21
US20120289591A1 (en) 2012-11-15
CA2781550C (en) 2018-01-23
US20220151969A1 (en) 2022-05-19
ES2643862T3 (es) 2017-11-24
CA2781550A1 (en) 2011-05-26
CN102639129A (zh) 2012-08-15
US11213503B2 (en) 2022-01-04
WO2011061237A1 (en) 2011-05-26
EP2501375B1 (en) 2017-07-19
US20170100357A1 (en) 2017-04-13
CN106236708B (zh) 2020-06-26
US20150157720A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
PL2501375T3 (pl) Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe
IL251846A0 (en) lipid preparations
HK1246216B (zh) 抗微生物組合物
GB2473460B (en) Antimicrobial Composition
IL217949A0 (en) Pesticdal compositions
EP2488022A4 (en) Compositions
ZA201109176B (en) Homeglobin compositions
EP2459189A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY ACTIVE SUBSTANCES
GB0906515D0 (en) Fungical compositions
EP2483233A4 (en) HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
IL214887A0 (en) Fatty acid monoglyceride compositions
ZA201202526B (en) Carrageenan-containing aqueous antimicrobial compositions
ZA201109312B (en) Compositions
IL216853A0 (en) Agricultural compositions
EP2404987A4 (en) PERFUME COMPOSITIONS
GB0915265D0 (en) Confectionery composition
IL219958A0 (en) Omega-3 fatty acid enriched meat compositions
IL214207A0 (en) Agricultural compositions
EP2485807A4 (en) SUN PROTECTION COMPOSITIONS
GB0904300D0 (en) Essential fatty acid compounds
GB0905165D0 (en) Compositions
IL216681A0 (en) Phenol ester as perfuming ingredient
EP2475712A4 (en) INITIATOR REINFORCED COMPOSITIONS
GB0911608D0 (en) Sanitising compositions
GB0918911D0 (en) Edible compositions